The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,585.00
Bid: 1,570.00
Ask: 1,600.00
Change: 30.00 (1.89%)
Spread: 30.00 (1.911%)
Open: 1,590.00
High: 1,620.00
Low: 1,585.00
Prev. Close: 1,590.00
CER Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Offer Update

10 Dec 2007 07:01

OAO Severstal10 December 2007 10 December 2007 RECOMMENDED REVISED CASH OFFER BY CENTROFERVE LIMITED A WHOLLY OWNED SUBSIDIARY OF SEVERSTAL FOR CELTIC RESOURCES HOLDINGS PLC OFFER UNCONDITIONAL AS TO ACCEPTANCES Centroferve, a wholly owned subsidiary of Severstal, announces that, as at 3.00p.m. on Friday 7 December 2007, acceptances of the Offer had been received inrespect of 45,294,217 Celtic Shares (representing approximately 81.1% of theCeltic Shares to which the Offer relates) and that, accordingly, the Offer isunconditional as to acceptances. If the Offer is declared unconditional in all respects, Celtic Shareholders whohave accepted or accept the Offer while it remains open for acceptance willreceive aggregate cash consideration of £2.90 per Celtic Share becauseCentroferve has received acceptances of the Offer in respect of 80% in value ofthe Celtic Shares for which the Offer was made, and the contingent cashconsideration described in the Revised Offer Document has therefore becomepayable. Having received acceptances of the Offer in respect of 80% of the Celtic Sharesto which the Offer relates, if the Offer is declared unconditional in allrespects Centroferve intends to exercise its right pursuant to the provisions ofSection 204 of the Companies Act 1963 to acquire the remaining Celtic Shares towhich the Offer relates on the same terms as the Offer. Centroferve did not hold any Celtic Shares before the commencement of the OfferPeriod and has not acquired or agreed to acquire any Celtic Shares during theOffer Period. Prior to the Offer Period, Bluecone, a company owned by Severstal, acquired12,281,946 Celtic Shares, and during the Offer Period (but before the OriginalOffer was made) Bluecone acquired a further 4,301,056 Celtic Shares. As aresult, Bluecone owns 16,583,002 Celtic Shares representing approximately 29.7%of the issued share capital of Celtic, and the acceptances referred to aboveinclude an acceptance of the Offer by Bluecone in respect of all of the CelticShares held by Bluecone. Other than the Celtic Shares held or acquired by Bluecone, no party acting inconcert with Centroferve held before the commencement of the Offer Period, oracquired or agreed to acquire during the Offer Period, any Celtic Shares. Terms defined in the Revised Offer Document dated 20 November 2007 have the samemeaning in this announcement unless otherwise stated. The Offer remains open for acceptance until 3.00pm (Dublin time) on 28 December2007. Enquiries: Centroferve Tel: +7 495 9810 910 ext.6633 Roman Deniskin Nikolai Zelenski Morgan Stanley & Co. Limited Tel: +44 20 7425 8000 Peter Bacchus Arash Mahdaviani FD London Tel: +44 207 831 3113 Jon Simmons Ben Brewerton The directors of Centroferve and the directors of Severstal acceptresponsibility for the information contained in this announcement. To the bestof the knowledge and belief of the directors of Centroferve and the directors ofSeverstal (who have taken all reasonable care to ensure that such is the case),the information contained in this announcement for which they acceptresponsibility is in accordance with the facts and does not omit anything likelyto affect the import of such information. Morgan Stanley & Co. Limited ("Morgan Stanley") is acting exclusively forCentroferve and Severstal Resurs and no one else in connection with the Offerand Morgan Stanley will not regard any other person as a client in relation tothe Offer and will not be responsible to anyone other than Centroferve andSeverstal Resurs for providing the protections afforded exclusively to itsclients or for providing advice in relation to the Offer, the contents of thisannouncement or any transaction or arrangement referred to herein. The Offer will not be made, directly or indirectly, in or into any jurisdictionwhere it would be unlawful to do so, or by use of the mails, or by any means orinstrumentality (including, without limitation, telephonically orelectronically) of interstate or foreign commerce, or by any facility of anational securities exchange of any jurisdiction where it would be unlawful todo so, and the Offer will not be capable of acceptance by any such means,instrumentality or facility from or within any jurisdiction where it would beunlawful to do so. Accordingly, copies of this announcement and all otherdocuments relating to the Offer are not being, and must not be, mailed orotherwise forwarded, distributed or sent in, into or from any jurisdiction whereit would be unlawful to do so. Persons receiving such documents (including,without limitation, nominees, trustees and custodians) should observe theserestrictions. Failure to do so may invalidate any related purported acceptanceof the Offer. Notwithstanding the foregoing restrictions, Centroferve reservesthe right to permit the Offer to be accepted if, in its sole discretion, it issatisfied that the transaction in question is exempt from or not subject to thelegislation or regulation giving rise to the restrictions in question. This announcement does not constitute an offer to sell or an invitation topurchase or the solicitation of an offer to purchase or subscribe for anysecurities. Any response in relation to the Offer should be made only on thebasis of the information contained in the Revised Offer Document or any documentby which the Offer is made. Any person who is a holder of 1% or more of the Celtic Shares may havedisclosure obligations under Rule 8.3 of the Takeover Rules, effective from thedate of the commencement of the Offer Period. The Offer will be made in the United States pursuant to an exemption from the UStender offer rules provided by Rule 14d-1(c) under the US Exchange Act. Notice to US holders of Celtic Shares: The Offer will be made for the securities of an Irish public limited companywhose shares are listed on the AIM market in the UK and is subject to Irish andUK disclosure requirements, which are different from those of the United States.The Offer will be made in the United States pursuant to applicable US tenderoffer rules and otherwise in accordance with the requirements of the IrishTakeover Rules. Accordingly, the Offer will be subject to disclosure and otherprocedural requirements, including with respect to withdrawal rights, offertimetable, settlement procedures and timing of payments that are different fromthose applicable under US domestic tender offer procedures and law. The receipt of cash pursuant to the Offer by a US holder of Celtic Shares may bea taxable transaction for US federal income tax purposes and under applicable USstate and local, as well as foreign and other tax laws. Each holder of CelticShares is urged to consult his independent professional adviser immediatelyregarding the tax consequences of acceptance of the Offer. It may be difficult for US holders of Celtic Shares to enforce their rights andany claim arising out of the US federal securities laws, since Centroferve andCeltic are located in non-US jurisdictions, and some or all of their officersand directors may be residents of non-US jurisdictions. US holders of CelticShares may not be able to sue a non-US company or its officers or directors in anon-US court for violations of the US securities laws. Further, it may bedifficult to compel a non-US company and its affiliates to subject themselves toa US court's judgement. In accordance with normal Irish and UK practice and pursuant to Rule 14e-5(b) ofthe US Exchange Act, Centroferve or its nominees, or its brokers (acting asagents), may from time to time make certain purchases of, or arrangements topurchase, Celtic Shares outside the United States, other than pursuant to theOffer, before or during the period in which the Offer remains open foracceptance. These purchases may occur either in the open market at prevailingprices or in private transactions at negotiated prices. Any information aboutsuch purchases will be disclosed as required in Ireland and the UK, will bereported to a Regulatory Information Service of the UK Listing Authority andwill be available on the London Stock Exchange website, www.londonstockexchange.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Nov 20207:00 amRNSFinal Results
18th Nov 20207:00 amRNSNew Three Year Managed Services Contract
6th Nov 20204:44 pmRNSHolding(s) in Company
6th Nov 20204:25 pmRNSHolding(s) in Company
6th Nov 20204:21 pmRNSHolding(s) in Company
27th Oct 20201:55 pmRNSHolding(s) in Company
20th Oct 202011:17 amRNSExercise of Options and Share Transfer
15th Oct 20207:00 amRNSTrading Update
16th Sep 20203:18 pmRNSHolding(s) in Company
15th Sep 20209:05 amRNSSecond Price Monitoring Extn
15th Sep 20209:00 amRNSPrice Monitoring Extension
15th Sep 20207:00 amRNSLargest Ever Contract Win
3rd Sep 202011:11 amRNSShare purchase for Long Term Incentive Plan
30th Jul 20203:08 pmRNSHolding(s) in Company
23rd Jul 20204:14 pmRNSHolding(s) in Company
1st Jul 20207:00 amRNSMajor Implementation Completed Remotely
10th Jun 20207:00 amRNSHolding(s) in Company
8th Jun 20205:43 pmRNSResult of Director Placing
8th Jun 20204:35 pmRNSProposed Director Placing
1st Jun 20207:00 amRNSDirector Retirement
11th May 20207:00 amRNSInterim Results
20th Apr 20207:00 amRNSHalf Year Trading Update
16th Mar 20207:00 amRNSChange of Adviser
10th Mar 20207:00 amRNSExercise of Options and Total Voting Rights
3rd Mar 20207:00 amRNSExercise of Options and Director/PDMR Shareholding
27th Feb 20204:45 pmRNSShare Purchase for Employee Share Option Scheme
26th Feb 20207:00 amRNSDirector/PDMR Shareholding
20th Feb 202011:52 amRNSHolding(s) in Company
13th Feb 20207:00 amRNSHolding(s) in Company
7th Feb 20209:57 amRNSResult of AGM
8th Jan 20208:58 amRNSHolding(s) in Company
8th Jan 20207:00 amRNSNotice of AGM
27th Nov 20192:52 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSFinal Results
20th Nov 20197:00 amRNSHolding(s) in Company
28th Oct 20197:00 amRNSTrading Update
14th Oct 20197:00 amRNSMajor Contract Win
26th Sep 20194:49 pmRNSHolding(s) in Company
9th Sep 20197:00 amRNSMajor New Contract Win
8th Aug 20194:14 pmRNSHolding(s) in Company
8th Aug 20194:13 pmRNSHolding(s) in Company
28th Jun 20197:00 amRNSHolding(s) in Company
25th Jun 20197:00 amRNSMajor Contract Win
14th Jun 20197:00 amRNSMajor New Contract Win
20th May 20197:00 amRNSInterim Results
2nd May 20197:00 amRNSTrading Update and Notice of Results
21st Feb 20197:00 amRNSGartner Magic Quadrant Report
14th Feb 20194:01 pmRNSEmployee Share Option Scheme
13th Feb 20197:00 amRNSMajor New Contract Win
8th Feb 20193:16 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.